SHANGHAI, Nov. 17 /PRNewswire-Asia/ -- Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, has filed its Form 10-Q report on operating results for the third quarter of 2009. Revenue for the third quarter was $4,076,445, an increase of $409,314, or 11.13%, when compared to the $3,677,131 in revenue for the same three-month period one year ago. Operating expenses increased to $1,185,015 from $932,422 as the Company continued its market expansion efforts. The net income for the three months ended September 30, 2009 and September 30, 2008 were $818,372 and $604,914, respectively.
For the nine months ended September 30, 2009, revenue was $10,451,465, a increase of $2,011,219, or 23.8%, when compared to the $8,440,246 for the nine months ended September 30, 2008. The net income for the nine months ended September 30, 2009 was $2,312,886 compared to $971,987 for the same period of 2008, with an increase of nearly 137%.
The Company's President and CEO, Mr. Xuelian Bian, said, "China's sterilization industry is meeting a very great opportunity once more. The current influenza preventions have verified that disinfection really is an important means to control the spread of A(H1N1) influenza. The Chinese Ministry of Health has attached great importance to disinfection for infection control in medical institutions. In addition to taking the A/H1N1 vaccination, the authorities concerned have asked the disinfectant enterprises to work with all levels of medical departments to deal with the next potential wave of the outbreak of Influenza A(H1N1)."
"We are very satisfied with the Company's outstanding performance in the third quarter, achieving our set goals. In spite of the increasingly fierce competition in the market, the Company still maintained over a 20% growth rate. Now with the Company's core competitive edge getting strengthened, we not only further expanded our customer base, but also understand, and are in control of, the whole market more thoroughly. "
"In order to cope with the continuing increase in market demand, we are planning to construct the laminar flow clean disinfectant workshop with its 1,500 square meter per GMP standard Jiading manufacturing center, which is planned to be completed in the first half of next year. The new workshop, it is estimated, will help double the liquid, gel preparation production capacity of Company. In addition, the initial plans for a new disinfectant powder workshop have just been finished and they are currently at the review and approval stage, with the project expected to be put into use early next year. Both of these projects will further increase the Company's core competitiveness, so as to consolidate the Company's No. 1 Brand position in China's medical disinfection market."
The full SEC report filed by Linkwell may be seen at: http://www.sec.gov/Archives/edgar/data/1042463/000114420409059728/v166465_10q.htm
About Linkwell Corporation
Linkwell Corporation, through its 90% ownership of its subsidiary, Linkwell Tech Group, Inc., develops, manufactures and distributes disinfectant healthcare products in China. Linkwell's disinfectant healthcare products are recognized as one of leading domestic Chinese brands in this market segment. Linkwell currently has 56 different products including disinfectants in liquid, tablet, powder and aerosol forms. Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.linkwell.us .
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These
forward- looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products; pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
